BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23566475)

  • 21. Epstein-Barr virus in hepatocellular carcinogenesis.
    Li W; Wu BA; Zeng YM; Chen GC; Li XX; Chen JT; Guo YW; Li MH; Zeng Y
    World J Gastroenterol; 2004 Dec; 10(23):3409-13. PubMed ID: 15526357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.
    Degasperi E; D'Ambrosio R; Iavarone M; Sangiovanni A; Aghemo A; Soffredini R; Borghi M; Lunghi G; Colombo M; Lampertico P
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1183-1191.e7. PubMed ID: 30613002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
    Fattovich G; Stroffolini T; Zagni I; Donato F
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S35-50. PubMed ID: 15508101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological, Diagnostic and Therapeutic Aspects of Hepatocellular Carcinoma in Morocco: A Case Series and Review of Literature.
    Zouaki I; Aiterrami A; Samlani Z; Oubaha S; Krati K
    Gulf J Oncolog; 2024 May; 1(45):75-90. PubMed ID: 38774936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of viral hepatitis aetiology on survival outcomes in hepatocellular carcinoma: A large multicentre cohort study.
    Mgaieth S; Kemp W; Gow P; Fink M; Lubel J; Nicoll A; Gazzola A; Hong T; Ryan M; Knight V; Dev AT; Sood S; Bell S; Paul E; Roberts SK
    J Viral Hepat; 2017 Nov; 24(11):982-989. PubMed ID: 28414893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular carcinoma in Ghana: a retrospective analysis of a tertiary hospital data.
    Tachi K; Agyei-Nkansah A; Archampong T
    Pan Afr Med J; 2020; 36():43. PubMed ID: 32774619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area.
    Kubicka S; Rudolph KL; Hanke M; Tietze MK; Tillmann HL; Trautwein C; Manns M
    Liver; 2000 Jul; 20(4):312-8. PubMed ID: 10959810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urine Neutrophil Gelatinase-Associated Lipocalin a Possible Diagnostic Marker for Egyptian Hepatocellular Carcinoma Patients.
    Abdelsameea E; Nada A; Omar N; Saleh SM; Naguib M; El-Ezawy HEM; Bakry L; Elsabaawy M
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2259-2264. PubMed ID: 32856853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Positive Hepatitis B Core Antibody and Metabolic Disorders in Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus.
    Lee HL; Bae SH; Lee J; Sung PS; Lee SW; Jang JW; Lee J; Choi JY; Han NI; Yoon SK
    Cancer Control; 2021; 28():10732748211039758. PubMed ID: 34569320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population.
    Chan SL; Mo FK; Johnson PJ; Liem GS; Chan TC; Poon MC; Ma BB; Leung TW; Lai PB; Chan AT; Mok TS; Yeo W
    J Gastroenterol Hepatol; 2011 Feb; 26(2):340-7. PubMed ID: 21261725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
    Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
    Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients.
    Utsunomiya T; Shimada M; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Takayama T; Kokudo N;
    Ann Surg; 2015 Mar; 261(3):513-20. PubMed ID: 25072437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of hepatitis B-associated hepatocellular carcinoma in Victoria.
    Sinclair M; Roberts S; Kemp W; Knight V; Dev A; Gow P; Philpott H; Kronborg I; Arachchi NJ; Bell S; Lim L; Gorelik A; Nicoll A;
    Intern Med J; 2013 May; 43(5):501-6. PubMed ID: 23279328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
    van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Next big threat for Pakistan Hepatocellular Carcinoma (HCC).
    Parkash O; Hamid S
    J Pak Med Assoc; 2016 Jun; 66(6):735-9. PubMed ID: 27339578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: A single center study.
    Ziada DH; El Sadany S; Soliman H; Abd-Elsalam S; Salama M; Hawash N; Selim A; Hamisa M; Elsabagh HM
    J Egypt Natl Canc Inst; 2016 Dec; 28(4):257-262. PubMed ID: 27378258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma.
    Kitab B; Ezzikouri S; Alaoui R; Nadir S; Badre W; Trepo C; Chemin I; Benjelloun S
    Liver Int; 2014 Jul; 34(6):e144-50. PubMed ID: 24502524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
    Song X; Wu A; Ding Z; Liang S; Zhang C
    Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.
    El-Maksoud MA; Habeeb MR; Ghazy HF; Nomir MM; Elalfy H; Abed S; Zaki MES
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):716-722. PubMed ID: 30870221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.